DIAMOND PV SERVICES LIMITED
Company number 06281854 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Risk Assessment: DIAMOND PV SERVICES LIMITED
1. Risk Rating: HIGH
The company's transition from an active trading entity with 30 employees and £1.83M in assets to dormant status represents a fundamental change in business operations. Combined with a reported loss of £213,026 in the last filed period, a near-doubling of current liabilities, and explicit going concern uncertainty noted in the accounts, this presents significant risk to any stakeholder.
2. Key Concerns
Concern 1: Dormant Status Following Active Trading
The most critical red flag is the reclassification to dormant status. The last filed accounts (March 2021) show a company with 30 employees, £1.83M in total assets, and active operations in general medical practice. The transition to dormant status strongly suggests the business has ceased operations entirely. This raises immediate questions about what has happened to the workforce, assets, and ongoing contractual obligations.
Concern 2: Significant Deterioration in Financial Position
The period ending March 2021 reveals several worrying trends: - Loss of £213,026 reported (compared to profit of £490,561 in the prior year) - Current liabilities nearly doubled from £625,575 to £1,236,187 - Trade creditors surged from £60,736 to £529,301 (approximately 772% increase) - New group undertaking liabilities of £321,789 appeared with no prior year equivalent - Trade debtors increased from £442,696 to £805,118, raising questions about collectability
Concern 3: Going Concern Uncertainty and Dividend Policy
The accounts explicitly state there is "a high level of uncertainty" about the company's ability to continue as a going concern, and that no adjustments have been made if it cannot. Despite this uncertainty and a £213,026 loss, the company paid £150,000 in dividends during the same period. This combination of paying dividends while reporting losses and expressing going concern doubts is a significant governance concern.
3. Positive Indicators
-
Cash Position: The company held £581,584 in cash as of March 2021, providing a liquidity buffer. However, given the dormant status, the current cash position is unknown and may differ significantly.
-
Positive Net Assets: Net assets of £574,908 indicate the company was solvent at the last reporting date, with shareholders' funds exceeding share capital.
-
Group Structure Support: The PSC is Propharma Group Mis Holdings Limited, which holds over 75% of shares and voting rights. This group connection may provide financial backing, though it also introduces intercompany dependency risks.
-
Filing Compliance: The company's confirmation statement and accounts are not overdue, suggesting basic administrative compliance is maintained.
-
Longevity: Incorporated in 2007, the company has a 17+ year operating history, suggesting some business resilience prior to recent difficulties.
4. Due Diligence Notes
| Item | Investigation Required |
|---|---|
| Dormant Status | Determine when and why the company became dormant. Is this permanent cessation of trade or temporary? What happened to the 30 employees? |
| Intercompany Balances | Amounts owed by group undertakings (£263,317) and to group undertakings (£321,789) require examination. Are these collectible? Are there offsetting arrangements? |
| Trade Creditor Surge | The increase from £60,736 to £529,301 in trade creditors needs explanation. Is this deferred payment due to cash preservation, or supplier disputes? |
| Trade Debtor Collectability | With £805,118 in trade debtors and the business now dormant, what provision has been made for bad debts? |
| Dividend Appropriateness | Investigate the rationale for £150,000 in dividends paid during a loss-making period with going concern doubts. Were solvency tests properly conducted? |
| COVID Impact & Recovery | The accounts reference COVID restrictions but are now over 3 years old. What is the current trading position? Has the medical practice resumed? |
| Propharma Group Relationship | Understand the nature of the group structure, any parent company guarantees, and whether group support would be available if needed. |
| Share Option Arrangement | £302,666 in share options was recognized. Clarify the terms, vesting conditions, and impact on future equity. |
| Year-End Change | The accounting reference date shifted from May 31 to March 1. Understand the commercial rationale for this change. |
| Current Financial Position | The most recent financial data is from March 2021 - over 3 years old. Obtain management accounts or updated filings to assess current position. |
Additional Observations
The PSC structure shows overlapping control: Propharma Group Mis Holdings Limited holds >75% of shares and voting rights, while name shown to subscribers holds 50-75% and name shown to subscribers holds 25-50%. This suggests a complex ownership arrangement, potentially involving different share classes or the corporate PSC holding shares on behalf of the individual PSCs. The relationship between these control structures should be clarified.
The presence of an American director (name shown to subscribers) in a UK general medical practice company is unusual and warrants understanding of their role and residency status for tax and regulatory purposes.